Crestor Indication Grows User Pool, But Self-Selection Hinders Statin Switch
This article was originally published in The Tan Sheet
Executive Summary
Switching statins OTC will require comprehensive consumer education to enable self-selection and flexibility from FDA on the types of information it considers product labeling